Main Article Content

Abstract


RÉSUMÉ
Objectif. La pandémie de COVID-19 a été cause d’une mortalité élevée chez les patients porteurs de comorbidités comme les pathologies cardiovasculaires. L’accélération de la mise sur marché des vaccins contre la pandémie a suscité une réticence envers ces derniers. L’étudié porte sur l’attitude des patients porteurs de pathologie cardiovasculaires vus en consultation cardiologique à Ouahigouya vis-à-vis de la vaccination contre la COVID-19. Population et méthodes. Une étude transversale a été menée du 1er au 25 avril 2022 dans trois cliniques privées de la ville de Ouahigouya. Nous avons inclus les patients consentants et porteurs de pathologie cardiovasculaire vus en consultation cardiologique. Le questionnaire était centré sur les connaissances, attitudes et pratiques de groupe vis-à-vis de la vaccination, notamment les raisons de ‘l’acceptation ou du refus de se faire vacciner. Résultats. Cent-un patients ont été interviewés. Le sex-ratio était 1,46 avec un âge moyen de 48,26 ± 11,93 ans. Les plus représentés étaient les travailleurs indépendants, les urbains, les musulmans, les non-scolarisés et les mariés. L’HTA et ses complications étaient les atteintes cardiovasculaires les plus fréquentes (93,07%). La proportion de vaccinés était de 55,45%. Les raisons les plus évoquées par les vaccinés pour se vacciner étaient pour se protéger (100%) et le suivi des Recommandations gouvernementales et des agents respectivement 78,52% et 72,21%. Les raisons de l’hésitation vaccinale les plus citées étaient : la COVID-19 est une maladie banale (62,22%) et la peur des effets secondaires (44,44%). Conclusion. La vaccination contre la COVID-19 devrait se poursuivre, accompagnée d’une sensibilisation efficace afin d’améliorer le taux de couverture vaccinale parmi les patients porteurs de pathologies cardiovasculaires.
ABSTRACT
Objective. COVID-19 pandemic has caused high mortality in patients with comorbidities such as cardiovascular pathologies. The acceleration of the marketing of vaccines against the pandemic has caused reluctance towards them. The study focuses on the attitude of patients with cardiovascular disease seen in cardiology consultation in Ouahigouya vis-à-vis COVID-19 vaccination. Population and methods. A cross-sectional study was conducted from April 1 to 25, 2022 in three private clinics of the city of Ouahigouya. We included consenting patients and carriers of cardiovascular pathology seen in cardiology consultation. Our main data of interest were the knowledge, attitude and practice of this population towards vaccination, especially the reasons for accepting or refusing vaccination. Results One hundred and one patients were interviewed. The sex ratio was 1.46 with an average age of 48.26 ± 11.93 years. The most represented were the self-employed, urban dwellers, Muslims, the uneducated and the married. Hypertension and its complications were the most common cardiovascular disorders (93.07%). The proportion of vaccinated was 55.45%. The reasons most mentioned by the vaccinated for getting vaccinated were to protect themselves (100%) and to follow government recommendations and agents, respectively 78.52% and 72.21%. The most cited reasons for vaccine hesitation were: COVID-19 is a common disease (62.22%) and fear of side effects (44.44%). Conclusion. Vaccination against COVID-19 must continue, accompanied by effective awareness-raising in order to improve the vaccination coverage rate among patients with cardiovascular pathologies.

Keywords

Vaccination coverage COVID-19 Cardiovascular disease Vaccine hesitancy Ouahigouya Couverture vaccination COVID-19 Pathologie cardiovasculaire Hésitation vaccinale Ouahigouya

Article Details

How to Cite
Ouedraogo Salam, Ouedraogo E Wm, Sawadogo Nongoba, Sawadogo Abdoulaye, Ouedraogo Hamadé, & Zabsonre P. (2022). Couverture Vaccinale et Raisons de l’Acceptation et de l’Hésitation à la Vaccination contre la COVID-19 chez les Patients Porteurs de Pathologie Cardiovasculaire à Ouahigouya. HEALTH SCIENCES AND DISEASE, 23(11). Retrieved from https://hsd-fmsb.org/index.php/hsd/article/view/4014

References

  1. Yahia F, Zakhama L, Ben Abdelaziz A. COVID-19 and Cardiovascular diseases. Scoping review study. La Tunisie medicale. 2020 ;98 (4) :283‑94.
  2. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 ; 27 :225–228
  3. Bongomin F, Olum R, Andia-Biraro I, Nakwagala FN, Hassan KH, Nassozi DR et al. COVID-19 vaccine acceptance among high-risk populations in Uganda. Ther. Adv. Infect. Dis. 2021 ; 8 : 1–15. DOI : 10.1177/ 20499361211024376
  4. Driggin E, Madhavan MV, Bikdeli B, Chuich TP, Laracy J, Biondi-Zoccai G, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. J Am Coll Cardiol. 2020 mai, 75 (18) 2352-2371
  5. Ministère de la santé et de l’hygiène publique du Burkina Faso. Vaccins contre la maladie à sars-cov2. La Lettre du CeDIM. 2022 ; 21 (6) :9-14. ISSN 0796-7802
  6. Sallam M. COVID-19 Vaccine Hesitancy Worldwide : A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines. 2021 ; 9 (2). https://doi.org/10.3390/ vaccines9020160
  7. Cooper S, Van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021 ;20(8) :921‑33
  8. MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope, and determinants. Vaccine (2015) 33:4161–4164
  9. OMS Afrique. Le Burkina Faso intensifie la vaccination contre la COVID -19. http://www.afro.who.int/fr/new. 20 décembre 2021 (consulté le 2 septembre 2022)
  10. Ijioma NE, Nze C. Evaluating the Influence of Social Media Use in COVID-19 Vaccine Hesitancy of Residents of Owerri Metropolis. AJC. 2022 ;10 (01):10‑24.
  11. Amani A, Njoh AA, Mouangue C , Zobel CLF , Mossus T. Vaccination Coverage and Safety in Cameroon:Descriptive Assessment of COVID-19 Infection in Vaccinated Individuals Couverture et sécurité vaccinales au Cameroun:analyse descriptive de l'infection au COVID-19 chez les personnes vaccinées. Health Sci. Dis. August2022 ; 23(8) :1-8http://www.hsd-fmsb.org/
  12. World Health Organization. Coronavirus (COVID-19) Dashboard. 2022. Available from: https://covid19. who.int/ (consulté le 2 septembre 2022)
  13. Yaméogo WNZ, Kabore S, Ouedraogo I, et al. Fight Against Covid-19 in Burkina Faso, Between Fear of the Disease and Reluctance to Vaccinate: Case of the University Hospital of Tengandogo. Int Jr Infect Dis & Epidemlgy. 2022;3(2):1‒5. DOI: 10.51626/ijide.2022.03.00021
  14. Oehler D, Bruno RR, Boeken U, Westenfeld R. Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation : Experiences from a German Transplant Centre. Transpl Infect Dis. 2021 ;23 (4): e13681. https://doi.org/10.1111/tid.13681
  15. Scoccimarro D, Panichi L, Ragghianti B, Silverii A, Mannucci E, Monami M. Sars-CoV2 vaccine hesitancy in Italy: A survey on subjects with diabetes. Nutr Metab Cardiovasc Dis. 28 oct 2021 ;31(11):3243‑6.
  16. Mikkilineni P, Simon R, Bhan A, Sudhaker D. Rao SD. Patient Perspectives on the COVID-19 Vaccine : A Pilot Survey Study of Patients in Endocrinology Clinics. Endocrine Practice (2022) ; 28 (9) :897-900. https://doi.org/10.1016/j.eprac.2022.06.010
  17. Hussain S, Ali F, Salahuddin N, Karim M, Naz S Khawaja RA et al. Perceptions Regarding COVID-19 Vaccination Among a Representative Pakistani Population Coming to Tertiary Care Cardiac Hospital. Cureus 13(10): e18654. doi:10.7759/cureus.18654
  18. Wang Y, Duan L, Li M, Wang J, Yang J, Song C et al. COVID-19 Vaccine Hesitancy and Associated Factors among Diabetes Patients: A Cross-Sectional Survey in Changzhi, Shanxi, China. Vaccines. 2022 ; 10, 129. https://doi.org/10.3390/vaccines10010129
  19. Oriji P, Allagoa D, Wagio T, Obagah L, Tekenah E, Ozori S. Hesitancy of COVID-19 Vaccination among Health Workers (Other than Doctors) in a Tertiary Hospital in South-South, Nigeria. Asian Journal of Research in Infectious Diseases.(2021); 7 (1) : 21-31.https://doi.org/10.9734/ajrid/2021/v7i130207
  20. Idrissa A, Hassimi A. Les difficultés de la gestion de la pandémie de la covid-19 au Niger. Sciences humaines. Disponiblesur:http://publication.lecames.org/index.php/hum/ article/view/2703 [consulté le 6 sept 2022]